A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention.
Saved in:
| Title: | A Phase 1 Clinical Trial to Assess the Safety and Pharmacokinetics of a Tenofovir Alafenamide/Elvitegravir Insert Administered Rectally for HIV Prevention. |
|---|---|
| Authors: | Riddler SA; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Kelly CW; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Hoesley CJ; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Department of Medical Education, University of Alabama at Birmingham, Birmingham, Alabama, USA., Ho KS; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Piper JM; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA., Edick S; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Heard F; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Doncel GF; CONRAD, Eastern Virginia Medical School, Norfolk, Virginia, USA., Johnson S; FHI 360, Durham, North Carolina, USA., Anderson PL; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Brand RM; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA., Kunjara Na Ayudhya RP; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA., Bauermeister JA; Department of Family and Community Health, University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania, USA., Hillier SL; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.; Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Hendrix CW; Department of Medicine, Clinical Pharmacology, Johns Hopkins University, Baltimore, Maryland, USA. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2024 Sep 23; Vol. 230 (3), pp. 696-705. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6613 |
|---|---|
| DOI: | 10.1093/infdis/jiae211 |
